Condition
HCV clinical trials and research
As of November 12, 2026, Find a Trial lists 7 HCV clinical trials that are recruiting, at sites in 6 countries (most in United States (3), Austria (1), Italy (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 6Countries
Newest HCV clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Bile acid and gut microbiota changes in people with hepatitis D starting bulevirtide | — | Roma | Recruiting | Feb 24, 2026 |
| MagIA H3S multiplex rapid blood test for HIV, hepatitis B and C, and syphilis | — | Abidjan and 1 other locations | Recruiting | Sep 12, 2025 |
| Scaling up same‑visit hepatitis C testing and treatment in Canada | — | Montreal, Quebec and 11 other locations | Recruiting | Jul 31, 2025 |
| Triple HIV/HBV/HCV screening alert in primary care | — | Dallas, Texas | Recruiting | Jun 22, 2025 |
| Untreated or Unknown HBV, HDV, and HCV in South-East Austria: See if People Need Care | — | Graz, Styra | Recruiting | Feb 19, 2025 |
| Preventing Hepatitis C in Kidney Transplant Recipients from Infected Donors | — | La Jolla, California and 8 other locations | Recruiting | Dec 16, 2022 |
| Peer-driven intervention to prevent HIV, HCV, and drug overdoses among people who inject drugs | — | Baltimore, Maryland | Recruiting | Apr 11, 2022 |
All recruiting trials (7)
-
Bile acid and gut microbiota changes in people with hepatitis D starting bulevirtide
This project will see if starting bulevirtide changes bile acids and gut bacteria in adults with chronic hepatitis D who are already on hepatitis B therapy.
-
MagIA H3S multiplex rapid blood test for HIV, hepatitis B and C, and syphilis
This project will test a single blood-based point-of-care test that checks for HIV, hepatitis B and C, and syphilis using serum or plasma samples from people at sites in Ivory Coast and Kenya.
-
Scaling up same‑visit hepatitis C testing and treatment in Canada
This project will test whether offering rapid on-site hepatitis C antibody and RNA tests in settings that serve people at risk can speed diagnosis and enable earlier treatment.
-
Triple HIV/HBV/HCV screening alert in primary care
Doctors in primary care will test a new EMR alert that suggests screening for HIV, HBV, and HCV when ordering blood tests for adults.
-
Untreated or Unknown HBV, HDV, and HCV in South-East Austria: See if People Need Care
This study looks at past test results to see how many people in South-East Austria have hepatitis B, hepatitis D coinfection, or hepatitis C that hasn’t been treated yet or isn’t known, and then invites them for care.
-
Preventing Hepatitis C in Kidney Transplant Recipients from Infected Donors
This study is testing whether starting Hepatitis C medication before or after a kidney transplant from an infected donor can better prevent infection in kidney transplant recipients.
-
Peer-driven intervention to prevent HIV, HCV, and drug overdoses among people who inject drugs
This study is testing whether getting support and education from peers can help people who inject drugs reduce their risk of HIV, hepatitis C, and overdoses.
Related topics
Quick answers
How many HCV clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (3 trials), Austria (1 trial), Italy (1 trial), Canada (1 trial), Côte d’Ivoire (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.